Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164619 · ClinicalTrials.gov registry record · Phase 2
Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 3,660
- Enrollment target
NCT00164619: Completed Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT00164619 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 3,660 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (2652% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164619, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3,660 participants
- Enrollment target
Study Summary
The purpose of the project is to determine whether the VOICES/VOCES intervention, that was shown to be effective in a research study, is still effective when delivered by STD/HIV prevention agencies. VOICES/VOCES is a brief, single-session intervention for African-American and Latino adult men and women at high risk for STD/HIV. It encourages condom use and improves condom negotiation skills. A health educator delivers the intervention to groups of 4 to 8 clinic patients in a private room. Groups are made up of people of the same sex and same race or ethnicity. Information on STD/HIV risk behaviors and condom use is delivered by culturally-specific videos, group discussion, and a poster presenting features of various condom brands. Participants role-play condom negotiation modeled in the videos. At the end of the session they are given sample condoms of their choice. In this project, health educators from the health departments of New York City and San Juan, Puerto Rico conducted the VOICES/VOCES intervention with a sample of patients from one STD clinic in each of their cities. Researchers helped the health departments test whether the intervention is effective when local health educators deliver it.
Interventions
- BEHAVIORAL VOICES/VOCES
- BIOLOGICAL Standard STD clinic services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,660 participants |
| Start Date | 2001-07 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
What the finished NCT00164619 record still lists
NCT00164619 is an interventional study that assigns participants to a tested intervention. Its 3,660 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (2652% higher).
The record links to 0 conditions, and to 2 interventions - of which VOICES/VOCES is the first listed.
NCT00164619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00164619 about?
NCT00164619 is a clinical study titled "Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR". The purpose of the project is to determine whether the VOICES/VOCES intervention, that was shown to be effective in a research study, is still effective when delivered by STD/HIV prevention agencies. VOICES/VOCES is a brief, single-session intervention for African-American and Latino adult men and ...
What is the current status of trial NCT00164619?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3,660 participants. The study started on 2001-07. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00164619?
The interventions under investigation include: VOICES/VOCES (BEHAVIORAL), Standard STD clinic services (BIOLOGICAL).
Who is sponsoring clinical trial NCT00164619?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00164619's enrollment target sits among peer trials
3,660 6th of 2000 higher than 1,995 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
- NCT07249398 · 3,650 participants · NA
Influence of Social Media Ads on Food Choice - Master Protocol
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia